Skip to main content

Advertisement

SpringerLink
Log in

Frequencies of human leukocyte antigen alleles and haplotypes among Japanese patients with age-related macular degeneration

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Stem cell therapy is a potential treatment for retinal disorders. We are currently exploring treating HLA matched patients of age-related macular degeneration (AMD) by using allogenic retinal pigment epithelium cells derived from induced pluripotent stem cells (iPS-RPE) from human leukocyte antigen (HLA) homozygote donors. The purpose of this study was to investigate the frequency of HLA class I and II alleles and haplotypes in Japanese patients with AMD.

Study design

Cross-sectional observation clinical study.

Methods

A total of 138 consecutive patients diagnosed with neovascular AMD (mean age, 76.0 ± 7.8 years, 105 men) and 300 controls were included in the study. The frequencies of HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 alleles were determined using illumina MiSeq platform. Frequencies of HLA alleles at six loci in patients with AMD were compared with those of the controls.

Results

The alleles with the highest prevalence at each locus were A*24:02 (29.7%), B*52:01 (15.5%), C*12:02 (16.1%), DRB1*09:01 (19.1%), DQB1*06:01 (23.2%), and DPB1* 05:01 (40.5%). There were no significant associations between the HLA alleles and AMD. The most common haplotype was A*24:02-B*52:01-C*12:02-DRB1*15:02-DQB1*06:01-DPB1*09:01, with a 9.8% genetic frequency among all haplotypes, detected in 18.8% of the patients.

Conclusion

The genotype of HLA in patients with AMD was not different from that in the Japanese control population. Thus, therapy with iPS-RPEof the most frequent HLA haplotype could be a feasible alternative for AMD in a wider population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med. 2000;342(7):483–92.

    Article  PubMed  CAS  Google Scholar 

  2. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: 2-year results of the ANCHOR study. Ophthalmology. 2009;116(57–65):e5.

    Google Scholar 

  3. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results. Ophthalmology. 2012;119:1388–98.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zarbin MA, Rosenfeld PJ. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina. 2010;30:1350–67.

    Article  PubMed  Google Scholar 

  5. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1994;232:707–16.

    Article  PubMed  CAS  Google Scholar 

  6. van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012;153(120–7):e2.

    Google Scholar 

  7. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.

    Article  PubMed  CAS  Google Scholar 

  8. Haruta M, Sasai Y, Kawasaki H, Amemiya K, Ooto S, Kitada M, et al. In vitro and In vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Investig Opthalmol Vis Sci. 2004;45:1020.

    Article  Google Scholar 

  9. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713–20.

    Article  PubMed  CAS  Google Scholar 

  10. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.

    Article  PubMed  CAS  Google Scholar 

  11. Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;376:1038–46.

    Article  PubMed  CAS  Google Scholar 

  12. Taylor CJ, Bolton EM, Bradley JA. Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci. 2011;366:2312–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood. 2012;120:2918–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Craig J, Wekerle T, Segev D, LEchler R, Oberbauer R. The tragedies for long term preservation of kidney graft function. Lancet. 2017;3(5):e15216.

    Google Scholar 

  16. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000;56:522–9.

    Article  PubMed  CAS  Google Scholar 

  17. Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, Tsujino T, et al. Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens. 2015;85:252–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Tokunaga K, Ishikawa Y, Ogawa A, Wang H, Mitsunaga S, Moriyama S, et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics. 1997;46:199–205.

    Article  PubMed  CAS  Google Scholar 

  19. Sugita S, Iwasaki Y, Makabe K, Kamao H, Mandai M, Shiina T, et al. Successful transplantation of retinal pigment epithelial cells from MHC homozygote iPSCs in MHC-matched models. Stem Cell Rep. 2016;7:635–48.

    Article  CAS  Google Scholar 

  20. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T cell response to iPSC-derived retinal pigment epithelial cells from HLA homozygous donors. Stem Cell Rep. 2016;7:619–34.

    Article  CAS  Google Scholar 

  21. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409–12.

    Article  PubMed  CAS  Google Scholar 

  22. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol. 2005;14:175–82.

    Article  PubMed  CAS  Google Scholar 

  23. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–32.

    Article  PubMed  CAS  Google Scholar 

  24. Penfold PL, Liew SC, Madigan MC, Provis JM. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38:2125–33.

    PubMed  CAS  Google Scholar 

  25. Goverdhan SV, Howell MW, Mullins RF, Osmond C, Hodgkins PR, Self J, et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:1726–34.

    Article  PubMed  Google Scholar 

  26. Goverdhan SV, Khakoo SI, Gaston H, Chen X, Lotery AJ. Age-related macular degeneration is associated with the HLA-Cw*0701 Genotype and the natural killer cell receptor AA haplotype. Invest Ophthalmol Vis Sci. 2008;49:5077–82.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Enrique V, Becerril RGF, Luis P. Torres, Manuel, José M Gallardo G. HLA B27 as predisposition factor to suffer age related macular degeneration. Cell Mol Immunol. 2009;6(4):303–7.

    Article  Google Scholar 

  28. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol. 2001;62:1009–30.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the HLA Foundation laboratory. Although this study did not receive specific funding, we received normal data from the HLA Foundation laboratory. We thank them for their help in providing the data. We thank Dr Noriko Miyamoto and Dr Akihiro Nishida for their help in acquisition of informed consent. We also thank for professor. Goji Tomita for helpful advice. This paper received editorial support from Editage.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Kobe City Eye Hospital, 2-1-8, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Seiji Takagi, Michiko Mandai, Yasuhiko Hirami, Sunao Sugita, Masayo Takahashi & Yasuo Kurimoto

  2. Department of Ophthalmology, Kobe City Medical Center General Hospital, 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Seiji Takagi, Michiko Mandai, Yasuhiko Hirami, Sunao Sugita, Masayo Takahashi & Yasuo Kurimoto

  3. Department of Ophthalmology, Toho University Ohashi Medical Center, 2-6-17 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan

    Seiji Takagi

  4. Laboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Michiko Mandai, Yasuhiko Hirami, Sunao Sugita, Masayo Takahashi & Yasuo Kurimoto

Authors
  1. Seiji Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michiko Mandai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiko Hirami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sunao Sugita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masayo Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuo Kurimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seiji Takagi.

Ethics declarations

Conflicts of interest

S. Takagi, Grant (Alcon, AMO, HOYA, Senju), Lecture fee (Alcon); M. Mandai, Grant (Sumitomo Dainippon Pharma, Tomey), Consultant fees (Alcon, Bayer, Healios, Otsuka, Santen, Senju); Y. Hirami, Grant (Alcon, AMO, HOYA, Senju), Lecture fees (Alcon, Bayer, Santen); S. Sugita, None; M. Takahashi, Grant (Healios, Hitachi, Nichirei Biosciences, Nitta Biolab, Sagawa, Sanplatec, Santen, Shibuya, Sumitomo Dainippon Pharma, Tomey), Consultant fees (Alcon, Astellas, DAI-DAN, Eisai, Healios, Novaris, Sysmex, Takeda, Topcon, Toray); Y. Kurimoto, Grant (Alcon, HOYA, Santen, Senju), Consultant fees (Alcon, AMO, Bayer, Cannon, Kowa, Otsuka, Pfizer, Santen, Senju).

Additional information

Corresponding author: Seiji Takagi

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takagi, S., Mandai, M., Hirami, Y. et al. Frequencies of human leukocyte antigen alleles and haplotypes among Japanese patients with age-related macular degeneration. Jpn J Ophthalmol 62, 568–575 (2018). https://doi.org/10.1007/s10384-018-0611-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-018-0611-8

Keywords

Search

Navigation